Modeling cholinergic abnormalities in Down syndrome and Alzheimer's disease.
Holtzman
D M
DM
Department of Neurology, University of California, San Francisco 94143.
Li
Y W
YW
Gage
F H
FH
DeArmond
S J
SJ
Epstein
C J
CJ
McKinley
M P
MP
Mobley
W C
WC
D000544:Alzheimer Disease / Q000473:pathology*; D000595:Amino Acid Sequence; D000818:Animals; D002799:Cholinergic Fibers / Q000473:pathology*; D004195:Disease Models, Animal; D004314:Down Syndrome / Q000473:pathology*; D005260:Female; D006624:Hippocampus / Q000378:metabolism / Q000473:pathology; D051379:Mice; D008806:Mice, Inbred AKR; D008969:Molecular Sequence Data; D009474:Neurons / Q000502:physiology / Q000637:transplantation; D009479:Neuropeptides / Q000096:biosynthesis / Q000235:genetics
D009479:Neuropeptides